Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
ASTRAZENECA PHARMACEUTICALS LP et al v. LUPIN LTD et al
Case Number:
3:12-cv-06888
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
April 11, 2013
AstraZeneca Settles Generic Seroquel XR Row With Lupin
AstraZeneca Pharmaceuticals LP settled its New Jersey patent infringement suit against Lupin Ltd. on Thursday, striking a deal in which Lupin agreed not to make or sell a generic version of AstraZeneca's extended-release schizophrenia drug Seroquel XR before November 2016.
-
November 09, 2012
AstraZeneca Sues To Block Lupin's Generic Seroquel XR
AstraZeneca Pharmaceuticals LP has hit Lupin Ltd. with a patent infringement suit in New Jersey federal court, adding the India-based drugmaker to the long list of companies it has sued for trying to market generic versions of extended-release schizophrenia drug Seroquel XR.